Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging lung cancer.

E F Patz1

  • 1Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.

Seminars in Oncology
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

This review details current imaging techniques for lung cancer diagnosis and staging. Advanced methods like positron emission tomography improve detection of primary tumors and metastases, aiding patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules.

Thorax·2007
Same author

Positron emission tomography imaging in lung cancer.

Clinical lung cancer·2004
Same author

Stage distribution in patients with a small (< or = 3 cm) primary nonsmall cell lung carcinoma. Implication for lung carcinoma screening.

Cancer·2001
Same author

CT screening for lung cancer: not ready for routine practice.

Radiology·2001
Same author

Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2001
Same author

Integration of peripheral blood biomarkers with computed tomography to differentiate benign from malignant pulmonary opacities.

Cancer detection and prevention·2001
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Imaging is crucial for lung cancer diagnosis, staging, and monitoring.
  • Chest radiographs detect most tumors; thoracic computed tomography stages local disease.
  • Radionuclide bone scans and brain imaging detect extrathoracic metastases in select cases.

Purpose of the Study:

  • To review current imaging modalities for evaluating lung cancer patients.
  • To highlight the role of advanced imaging in disease assessment.

Main Methods:

  • Review of current diagnostic imaging techniques for lung cancer.
  • Discussion of chest radiography, computed tomography, and radionuclide imaging.
  • Emphasis on positron emission tomography for comprehensive staging.

Related Experiment Videos

Main Results:

  • Chest radiography and computed tomography are standard for initial evaluation and local staging.
  • Positron emission tomography offers a comprehensive assessment of primary tumors, lymph nodes, and distant metastases.
  • Various imaging techniques are employed based on patient-specific needs for metastasis detection.

Conclusions:

  • Current imaging techniques are vital for lung cancer management.
  • Advancements in imaging, risk stratification, and therapeutics promise improved survival rates.
  • Continued evolution of diagnostic imaging will enhance patient outcomes in lung cancer care.